Resol Life Support Co., Ltd. announced that it expects to receive ¥624.5 million in funding from Advantage Risk Management Co., Ltd.
March 18, 2021
Share
Resol Life Support Co., Ltd. announced that it will receive ¥624,500,000 in an equity round of funding on March 19, 2021. The transaction will include participation from Advantage Risk Management Co., Ltd. (TSE:8769). The company will raise the funding through third party allotment method. The transaction has been approved by board of directors of the investor. Post-closing of the transaction investor will acquire 49% stake in the company. The company expects to close the transaction on April 9, 2021.
Advantage Risk Management Co Ltd is a Japan-based company mainly engaged in the mental disability support activities, group long-term disability compensation insurance, and risk finance business. The Company operates through three segments. The Mental Health Care segment is engaged in the provision of mental health care services ranging from stress checks to counseling, organizational analysis, subsequent solutions, and aptitude tests for recruitment based on stress tolerance and emotional intelligence (EQ). The Employment Disability Support segment is engaged in the provision of comprehensive services related to Group Long-Term Disability (GLTD) insurance, offering sales of insurance products and professional know-how and supplementary services including system design, proposals, consulting and support for returning to work. The Risk Financing segment sells individual insurance products, such as cancer insurance, mainly to individuals working for companies and other organizations.
ADVANTAGE RISK MANAGEMENT CO., LTD. 
